Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients
- 31 March 2010
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 46 (5), 944-953
- https://doi.org/10.1016/j.ejca.2009.12.019
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapyGynecologic Oncology, 2006
- Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinomaInternational Journal of Cancer, 2004
- Future directions in the surgical management of ovarian cancerGynecologic Oncology, 2003
- EPITHELIAL OVARIAN CANCERPublished by Elsevier BV ,2002
- Gene Expression Profiles in Normal and Cancer CellsScience, 1997
- Cloning of the gene encoding TROP‐2, a cell‐surface glycoprotein expressed by human carcinomasInternational Journal of Cancer, 1995
- The epithelial/carcinoma antigen EGP‐1, recognized by monoclonal antibody RS7–3G11, is phosphorylated on serine 303International Journal of Cancer, 1995
- Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificityInternational Journal of Cancer, 1987
- Human trophoblast cell-surface antigens defined by monoclonal antibodies.Proceedings of the National Academy of Sciences of the United States of America, 1981